Published in Environ Health Perspect on August 25, 2010
Developmental Effects of the ToxCast™ Phase I and Phase II Chemicals in Caenorhabditis elegans and Corresponding Responses in Zebrafish, Rats, and Rabbits. Environ Health Perspect (2015) 0.80
Biomarkers linking PCB exposure and obesity. Curr Pharm Biotechnol (2014) 0.80
Behavioral and metabolic effects of the atypical antipsychotic ziprasidone on the nematode Caenorhabditis elegans. PLoS One (2013) 0.79
Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice. Int J Mol Sci (2014) 0.76
Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View. Mol Neurobiol (2016) 0.75
Epigenetics, obesity and early-life cadmium or lead exposure. Epigenomics (2016) 0.75
Genome sequence of the nematode C. elegans: a platform for investigating biology. Science (1998) 61.48
The structure of the nervous system of the nematode Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci (1986) 27.07
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol (1977) 19.51
Weight-reducing effects of the plasma protein encoded by the obese gene. Science (1995) 13.05
Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science (1995) 9.09
Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature (2003) 7.80
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol (2004) 6.14
C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron (2000) 6.00
Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell (2008) 5.60
The life cycle of the nematode Caenorhabditis elegans. I. Wild-type growth and reproduction. Dev Biol (1976) 5.27
Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol (2009) 4.52
The Caenorhabditis elegans male: postembryonic development of nongonadal structures. Dev Biol (1980) 4.38
Neurobiology of the Caenorhabditis elegans genome. Science (1998) 4.34
SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response. Genes Dev (2003) 3.92
Serotonin and octopamine in the nematode Caenorhabditis elegans. Science (1982) 3.68
Dopaminergic neurons in the nematode Caenorhabditis elegans. J Comp Neurol (1975) 3.68
Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet (2009) 3.59
G-protein signaling through tubby proteins. Science (2001) 3.59
Global analysis of dauer gene expression in Caenorhabditis elegans. Development (2003) 3.38
The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci (1953) 3.03
Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage (2006) 2.94
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A (1985) 2.85
C. elegans major fats are stored in vesicles distinct from lysosome-related organelles. Cell Metab (2009) 2.85
The C. elegans p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response. Genes Dev (2005) 2.81
A Caenorhabditis elegans nutrient response system partially dependent on nuclear receptor NHR-49. Proc Natl Acad Sci U S A (2005) 2.69
Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy. Proc Natl Acad Sci U S A (2007) 2.65
A calcium-channel homologue required for adaptation to dopamine and serotonin in Caenorhabditis elegans. Nature (1995) 2.61
Tyramine and octopamine: ruling behavior and metabolism. Annu Rev Entomol (2005) 2.60
Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci (2007) 2.59
Dopamine and glutamate control area-restricted search behavior in Caenorhabditis elegans. J Neurosci (2004) 2.59
C elegans: a model for exploring the genetics of fat storage. Dev Cell (2003) 2.56
Polygenic control of Caenorhabditis elegans fat storage. Nat Genet (2006) 2.46
Cilium-generated signaling and cilia-related disorders. Lab Invest (2005) 2.42
Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety. Cell Metab (2008) 2.31
Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity (Silver Spring) (2008) 2.30
Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol (2007) 2.17
The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem (2006) 2.13
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc Natl Acad Sci U S A (2008) 2.09
Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J Biol Chem (2005) 2.07
The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J Neurosci (1999) 2.06
Serotonin-deficient mutants and male mating behavior in the nematode Caenorhabditis elegans. J Neurosci (1993) 2.03
Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2002) 2.01
Serotonin regulates C. elegans fat and feeding through independent molecular mechanisms. Cell Metab (2008) 1.99
A candidate gene for the mouse mutation tubby. Nature (1996) 1.95
Manganese neurotoxicity. Ann N Y Acad Sci (2004) 1.94
Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med (1997) 1.92
Superoxide dismutase from Bacillus stearothermophilus. Complete amino acid sequence of a manganese enzyme. Biochemistry (1980) 1.86
Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans. J Neurosci (1995) 1.85
Structure and gene expression of the E. coli Mn-superoxide dismutase gene. Nucleic Acids Res (1986) 1.83
LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins. Curr Biol (2007) 1.76
The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol (2005) 1.74
Remarkable longevity and stress resistance of nematode PI3K-null mutants. Aging Cell (2007) 1.71
Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem (2003) 1.70
Obesity and the regulation of fat metabolism. WormBook (2007) 1.67
Patterning of dopaminergic neurotransmitter identity among Caenorhabditis elegans ray sensory neurons by a TGFbeta family signaling pathway and a Hox gene. Development (1999) 1.67
Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect (2010) 1.66
Modulation of food reward by adiposity signals. Physiol Behav (2006) 1.65
Biogenic amine neurotransmitters in C. elegans. WormBook (2007) 1.64
Withdrawal of sibutramine in Europe. BMJ (2010) 1.64
Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci (1999) 1.58
Norepinephrine: The redheaded stepchild of Parkinson's disease. Biochem Pharmacol (2007) 1.57
Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology (2008) 1.53
Alternate metabolism during the dauer stage of the nematode Caenorhabditis elegans. Exp Gerontol (2005) 1.50
Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm (Vienna) (1996) 1.45
Hypothalamic neurodegeneration and adult-onset obesity in mice lacking the Ubb polyubiquitin gene. Proc Natl Acad Sci U S A (2008) 1.41
The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. Mol Pharmacol (1998) 1.41
Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J Biol Chem (2009) 1.36
Mitochondrial complex I mutations in Caenorhabditis elegans produce cytochrome c oxidase deficiency, oxidative stress and vitamin-responsive lactic acidosis. Hum Mol Genet (2003) 1.33
C. elegans tubby regulates life span and fat storage by two independent mechanisms. Cell Metab (2005) 1.28
SAGE surveys C. elegans carbohydrate metabolism: evidence for an anaerobic shift in the long-lived dauer larva. Mech Ageing Dev (2003) 1.26
Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J Alzheimers Dis (2008) 1.26
Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther (2006) 1.26
Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans. PLoS One (2007) 1.25
C. elegans fat storage and metabolic regulation. Biochim Biophys Acta (2009) 1.24
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science (1989) 1.24
Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet (2010) 1.23
Serotonin regulates repolarization of the C. elegans pharyngeal muscle. J Exp Biol (2003) 1.23
Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. Neurodegener Dis (2004) 1.21
Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ Health Perspect (2008) 1.19
Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect (2005) 1.17
Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl (1997) 1.16
Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity. J Clin Invest (1997) 1.15
Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol (1976) 1.15
Obesity is a modifier of autonomic cardiac responses to fine metal particulates. Environ Health Perspect (2007) 1.15
Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology (2009) 1.14
The use of FUdR can cause prolonged longevity in mutant nematodes. Mech Ageing Dev (2010) 1.13
Zinc and disease of the brain. Mol Neurobiol (2002) 1.12
SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans. PLoS One (2009) 1.11
Bardet-Biedl syndrome gene variants are associated with both childhood and adult common obesity in French Caucasians. Diabetes (2006) 1.11
Glutamine synthetase: the major Mn(II) enzyme in mammalian brain. Curr Top Cell Regul (1984) 1.11
Antipsychotic drugs disrupt normal development in Caenorhabditis elegans via additional mechanisms besides dopamine and serotonin receptors. Pharmacol Res (2006) 1.09
The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in caenorhabditis elegans models of manganism and parkinson disease. J Biol Chem (2009) 1.07
Understanding the mind of a worm: hierarchical network structure underlying nervous system function in C. elegans. Prog Brain Res (2008) 1.07
Dual excitatory and inhibitory serotonergic inputs modulate egg laying in Caenorhabditis elegans. Genetics (2008) 1.05
Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem Rev (2009) 1.04
The metabolomic responses of Caenorhabditis elegans to cadmium are largely independent of metallothionein status, but dominated by changes in cystathionine and phytochelatins. J Proteome Res (2009) 1.04
Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons. Ann Neurol (2006) 1.03
Manganese-induced apoptosis in PC12 cells. Neurotoxicol Teratol (2002) 1.03
Copper (Cu2+) induces degeneration of dopaminergic neurons in the nigrostriatal system of rats. Neurosci Bull (2008) 1.01
Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci (2008) 2.49
Manganese neurotoxicity may underlie the association between early life iron deficiency and impaired spatial cognition in neonatal piglets. J Nutr (2013) 2.16
Nutritional aspects of manganese homeostasis. Mol Aspects Med (2005) 2.03
The V0-ATPase mediates apical secretion of exosomes containing Hedgehog-related proteins in Caenorhabditis elegans. J Cell Biol (2006) 1.99
Manganese neurotoxicity. Ann N Y Acad Sci (2004) 1.94
Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol (2011) 1.73
Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase. Neurotoxicology (2011) 1.56
Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol (2003) 1.55
Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology (2008) 1.53
The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology (2011) 1.51
Overexpression of Toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice. J Immunol (2003) 1.36
Developmental neuropathology of environmental agents. Annu Rev Pharmacol Toxicol (2004) 1.28
Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol (2011) 1.28
Anticholinesterase toxicity and oxidative stress. ScientificWorldJournal (2006) 1.27
Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther (2006) 1.26
Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity. Neurotoxicology (2006) 1.25
Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet (2010) 1.23
Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2009) 1.23
Manganese accumulates in iron-deficient rat brain regions in a heterogeneous fashion and is associated with neurochemical alterations. Biol Trace Elem Res (2002) 1.23
Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J Neurochem (2009) 1.23
Interactions between excessive manganese exposures and dietary iron-deficiency in neurodegeneration. Environ Toxicol Pharmacol (2005) 1.22
Down-regulation of early ionotrophic glutamate receptor subunit developmental expression as a mechanism for observed plasticity deficits following gestational exposure to benzo(a)pyrene. Neurotoxicology (2007) 1.22
Manganese neurotoxicity and glutamate-GABA interaction. Neurochem Int (2003) 1.20
Glutathione modulation influences methyl mercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. Neurotoxicology (2006) 1.20
Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol Sci (2007) 1.20
Anthranilate fluorescence marks a calcium-propagated necrotic wave that promotes organismal death in C. elegans. PLoS Biol (2013) 1.18
Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup Environ Med (2012) 1.17
Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci (2011) 1.16
In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect (2010) 1.16
Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. Neurotoxicology (2008) 1.15
Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity. Exp Neurol (2007) 1.15
SyM-BBB: a microfluidic Blood Brain Barrier model. Lab Chip (2013) 1.12
Genes required for osmoregulation and apical secretion in Caenorhabditis elegans. Genetics (2006) 1.12
SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans. PLoS One (2009) 1.11
Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers (2009) 1.11
Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol Sci (2006) 1.11
Roles of glutamine in neurotransmission. Neuron Glia Biol (2011) 1.11
Globus pallidus: a target brain region for divalent metal accumulation associated with dietary iron deficiency. J Nutr Biochem (2004) 1.09
Manganese exposure and induced oxidative stress in the rat brain. Sci Total Environ (2004) 1.08
Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology (2004) 1.08
Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol (2007) 1.07
Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. J Neurochem (2009) 1.06
Pathophysiology of manganese-associated neurotoxicity. Neurotoxicology (2011) 1.06
Role of astrocytes in brain function and disease. Toxicol Pathol (2010) 1.06
A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol Sci (2006) 1.05
Methylmercury induces acute oxidative stress, altering Nrf2 protein level in primary microglial cells. Toxicol Sci (2010) 1.05
The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int (2006) 1.05
Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes. J Neurochem (2009) 1.04
Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem Rev (2009) 1.04
Prenatal exposure to benzo(a)pyrene impairs later-life cortical neuronal function. Neurotoxicology (2008) 1.03
Determining the oxidation states of manganese in NT2 cells and cultured astrocytes. Neurobiol Aging (2005) 1.03
Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes. Brain Res (2006) 1.03
Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes. Brain Res Mol Brain Res (2005) 1.03
Manganese Is Essential for Neuronal Health. Annu Rev Nutr (2015) 1.03
The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter. J Neurochem (2008) 1.02
Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci (2008) 1.02
Methylmercury-induced reactive oxygen species formation in neonatal cerebral astrocytic cultures is attenuated by antioxidants. Brain Res Mol Brain Res (2003) 1.01
Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure. J Neurochem (2009) 1.00
Prenatal polycyclic aromatic hydrocarbon exposure leads to behavioral deficits and downregulation of receptor tyrosine kinase, MET. Toxicol Sci (2010) 1.00
Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology (2002) 1.00
Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures. Brain Res (2008) 0.99
Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury. Neurochem Int (2012) 0.99
Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter. Neurotoxicology (2005) 0.99
Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol Sci (2007) 0.99
Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicol Sci (2009) 0.98
Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. Toxicol Appl Pharmacol (2009) 0.98
Modulation of cholinergic systems by manganese. Neurotoxicology (2007) 0.98
Manganese (Mn) and iron (Fe): interdependency of transport and regulation. Neurotox Res (2009) 0.98
Methylmercury-induced alterations in astrocyte functions are attenuated by ebselen. Neurotoxicology (2011) 0.98
Measurement of isoprostanes as markers of oxidative stress in neuronal tissue. Curr Protoc Toxicol (2009) 0.97
Leaching of trace elements from biological tissue by formalin fixation. Biol Trace Elem Res (2007) 0.97
GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes. J Biol Chem (2012) 0.96
Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons. Neurotoxicology (2010) 0.96
Free radical formation in cerebral cortical astrocytes in culture induced by methylmercury. Brain Res Mol Brain Res (2004) 0.96
Retracted Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice. Am J Physiol Heart Circ Physiol (2007) 0.96
Neonatal rat primary microglia: isolation, culturing, and selected applications. Curr Protoc Toxicol (2010) 0.95
Characterization of the effects of methylmercury on Caenorhabditis elegans. Toxicol Appl Pharmacol (2009) 0.94
The importance of glutamate, glycine, and gamma-aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. Toxicol Appl Pharmacol (2005) 0.94
Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia (2011) 0.93
A chronic iron-deficient/high-manganese diet in rodents results in increased brain oxidative stress and behavioral deficits in the morris water maze. Neurotox Res (2009) 0.93
Transforming growth factor-α mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes. Glia (2012) 0.92
Role of astrocytes in manganese mediated neurotoxicity. BMC Pharmacol Toxicol (2013) 0.92
trans-10,cis-12-Conjugated linoleic acid instigates inflammation in human adipocytes compared with preadipocytes. J Biol Chem (2010) 0.92
Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. PLoS One (2012) 0.92
Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice. Brain Res Bull (2008) 0.92
Methylmercury toxicity and Nrf2-dependent detoxification in astrocytes. Toxicol Sci (2008) 0.92
Hormetic effect of methylmercury on Caenorhabditis elegans. Toxicol Appl Pharmacol (2010) 0.92
Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol Sci (2010) 0.92
Measurement of isoprostanes as markers of oxidative stress. Methods Mol Biol (2011) 0.91
Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity. Neurotoxicology (2011) 0.91
Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system. Toxicol Sci (2010) 0.91
Utility of Caenorhabditis elegans in high throughput neurotoxicological research. Neurotoxicol Teratol (2008) 0.91
Manganese in health and disease. Met Ions Life Sci (2013) 0.91
Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport. Neurotoxicology (2003) 0.91